{"id":"W2984671704","doi":"10.1200/jco.2009.27.15_suppl.7027","title":"Subcutaneous omacetaxine mepesuccinate in chronic myeloid leukemia (CML) patients resistant or intolerant to two or more tyrosine kinase inhibitors (TKIs): Data from an ongoing phase II trial","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Regimen; Phases of clinical research; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008728856,0.0009671919,0.001367064,0.0002223169,0.0002301766,0.0005277899,0.0004243853,0.0007748625,0.0033539],"category_scores_gemma":[0.0005629014,0.0002449824,0.0007781932,0.0003414443,0.0004640275,0.0004905178,0.000222432,0.001602295,0.0006545831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000363183,"about_ca_system_score_gemma":0.0007205554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006184596,"about_ca_topic_score_gemma":0.001579943,"domain_scores_codex":[0.9998277,0.0000742714,0.00001262124,0.00002229543,0.00001769642,0.00004533119],"domain_scores_gemma":[0.999419,0.0001513229,0.0001086798,0.00003043175,0.00002624855,0.0002644757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6997039,0.02642282,0.009596457,0.001836002,0.001449887,0.000535487,0.0002946939,0.002150308,0.04099162,0.0003055542,0.006604464,0.2101087],"study_design_scores_gemma":[0.6566405,0.3184024,0.01620404,0.0000932212,0.0004189174,0.0005723088,0.0000636201,0.001200482,0.002469151,0.0001734864,0.003738646,0.00002321181],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924799,0.004049666,0.0002833596,0.0003791256,0.00007026173,0.0007186367,0.0004432047,0.00004095635,0.001534911],"genre_scores_gemma":[0.988607,0.00464797,0.0007690504,0.0009195169,0.0001843584,0.0008800779,0.001951668,0.00001581214,0.002024537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0033539,"threshold_uncertainty_score":0.01121992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1223123378830397,"score_gpt":0.4804999839927469,"score_spread":0.3581876461097072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}